Zum Inhalt springen

Blood test detects early Alzheimer’s with 90% accuracy, semaglutide shows cognitive benefits in trials

Semaglutide shows unexpected cognitive benefits in early trials

The Alzheimer’s Association International Conference in Chicago unveiled a blood test that detects early signs of Alzheimer’s with 90% accuracy, offering a less invasive alternative to spinal taps or brain scans. Neurology professor Christoph Kleinschnitz, who attended the congress, explained …